findmyKOL

James Wolosin, MD

Basic profile

Sharp Rees-Stealy Medical Group

ORCIDNone on fileNPI
RegionSan Diego, CA · WestSpecialtyGastroenterologyFocusGastroenterology
Last active 2013findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2013Online presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

James Wolosin is a Gastroenterology physician affiliated with Sharp Rees-Stealy Medical Group. OpenAlex indexes 7 publications with 242 citations (h-index 7).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
7publications

Distinct works indexed by OpenAlex.

242citations

Total citations across indexed works.

7h-index

Hirsch index, productivity × impact (OpenAlex).

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    66.9%
    Benzodiazepine53.5%
    Midazolam hydrochloride100%
    Part B, office-administered109 patients
    Opioid Agonist11.9%
    Fentanyl citrate100%
    Part B, office-administered98 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    26.3%
    Proton pump inhibitor9%
    Pantoprazole Sodium52%Omeprazole48%
    Part D22 patients
    Aminosalicylate4.8%
    Mesalamine100%
    Part D12 patients

    + 8 more classes in this area

  • Cancer & immunology

    3.6%
    Calcineurin inhibitor1.9%
    Tacrolimus100%
    Part D<11 patients
    Purine Antimetabolite1.7%
    Azathioprine100%
    Part D<11 patients
Where care is delivered (Part B)3.4% facility · 96.6% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

2 more publications behind the reveal.Reveal →

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”